Immunotherapy in small bowel adenocarcinoma: a potential role?
Immunol Med
; 47(1): 1-5, 2024 Mar.
Article
en En
| MEDLINE
| ID: mdl-37293784
Small bowel adenocarcinoma (SBA) is a rare tumor with an unfavorable prognosis, and due to its rarity, few studies on its treatment are available. Chemotherapy remains the standard of treatment in advanced disease. Recently immunotherapy has demonstrated to be a valid therapeutic option for many solid tumors. We reviewed the data published in literature to understand the impact of immunotherapy in this cancer.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Adenocarcinoma
/
Neoplasias Duodenales
/
Neoplasias del Íleon
/
Neoplasias del Yeyuno
Límite:
Humans
Idioma:
En
Revista:
Immunol Med
Año:
2024
Tipo del documento:
Article
País de afiliación:
Italia
Pais de publicación:
Reino Unido